Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefano Rocco
Major Molecular Response Induced by Nilotinib as First Line Treatment in a LMC Patient With Intermediate Sokal Risk
Clinical Management Issues
Medicine
Accounting
Management
Business
Non-Urgent Patients in the Emergency Departement
Emergency Care Journal
Related publications
Complete Molecular Response Induced by Nilotinib in a Patient Previously Treated With Imatinib, Nilotinib and Dasatinib
Clinical Management Issues
Medicine
Accounting
Management
Business
Nilotinib in Der First-Line Zugelassen
Info Onkologie
Nilotinib Übertrifft Imatinib in Der First-Line Weiterhin
Info Onkologie
Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Single Patient Experience
American Journal of Hematology
Hematology
Development of Myasthenia Gravis in a Patient With Chronic Myeloid Leukemia During Treatment With Nilotinib
Hematology Reports
Hematology
Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Second Experience
American Journal of Hematology
Hematology
Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P3.15-27 Initial Response to First Line Treatment Is the Best Predictor of the Patient Survival in Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Long-Term Response to First-Line Trabectedin in an Elderly Female Patient With a Metastatic Leiomyosarcoma Unfit for Anthracycline
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology